Financial statements Delfarma
Cash inflows of DELFARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 5 363 455,52 | 6 687 723,57 | 7 105 170,39 | 7 592 429,56 | 1 867 444,21 | 727 894,69 |
| Net cash flow from investing activities | -873 308,23 | -1 127 630,20 | -468 848,15 | -646 906,19 | -451 759,54 | -1 429 142,84 |
| Net cash flow from financial activities | -4 487 696,84 | -4 528 892,08 | -7 595 686,51 | -6 828 137,28 | -1 068 436,71 | 426 788,68 |
| Total net cash flow | 2 450,45 | 1 031 201,29 | -959 364,27 | 117 386,09 | 347 247,96 | -274 459,47 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.